Patients’ perceptions and considerations regarding DNA testing in a memory clinic: DNA‐ABOARD

IF 13 1区 医学 Q1 CLINICAL NEUROLOGY Alzheimer's & Dementia Pub Date : 2025-01-09 DOI:10.1002/alz.091187
Jetske van der Schaar, Sven J van der Lee, Eva Asscher, Wiesje M. van der Flier, Yolande A.L. Pijnenburg, Annelien L. Bredenoord, Mariette A. van den Hoven, Ellen M.A. Smets, Leonie N.C. Visser
{"title":"Patients’ perceptions and considerations regarding DNA testing in a memory clinic: DNA‐ABOARD","authors":"Jetske van der Schaar, Sven J van der Lee, Eva Asscher, Wiesje M. van der Flier, Yolande A.L. Pijnenburg, Annelien L. Bredenoord, Mariette A. van den Hoven, Ellen M.A. Smets, Leonie N.C. Visser","doi":"10.1002/alz.091187","DOIUrl":null,"url":null,"abstract":"BackgroundData‐driven criteria for DNA testing were implemented in routine care of Alzheimer Center Amsterdam. We aimed to explore patients’ perspectives and considerations regarding their decision to (not) be tested for a monogenic cause of their disease.MethodsIn this mixed method study, 150 of 519 new patients visiting Alzheimer Center Amsterdam who fulfilled the criteria were offered DNA‐diagnostics: 86(57%) accepted, 64(43%) did not. In 65/86(76%) cases results were negative, in 14/86(16%) a monogenic cause and in 7/86 (8%) variants of uncertain significance were found (<jats:italic>Figure 1)</jats:italic>. Sex, age, education, family history of dementia, MMSE and diagnosis were retrieved. Before discussing DNA testing, patients completed a questionnaire assessing perceived risk of a genetic cause, susceptibility for, severity of, and experience with dementia, social support, coping strategies, anxiety, depression, and quality of life. Differences between those who did and did not consent to DNA testing were calculated using Pearson’s χ², Mann‐Whitney U or Independent Samples t‐tests; p‐values were FDR‐adjusted. A subset of 22 patients and/or relatives participated in semi‐structured interviews on motivations and considerations regarding their decision. Verbatim transcripts were analyzed inductively using MAXQDA‐software.ResultsParticipants (n = 150) were 46% female and aged 61±8 (MMSE = 22±6, 5 Subjective Cognitive Decline, 9 MCI, 104 dementia [69 AD, 13 FTD, 22 other], 32 other/undetermined). Adjusted for multiple testing, no demographic, medical or psychosocial factors were associated with the decision on DNA testing (all <jats:italic>p</jats:italic>&gt;0.05). Twenty‐one interviewees who agreed to DNA testing were generally motivated by obtaining information on heredity for their relatives, contributing to scientific research into a treatment, and gaining insight in the cause of their disease. One patient had blood stored, allowing their children to test it when opportune. The majority decided quickly, mostly on intuitions (e.g., responsibility towards relatives) rather than facts (e.g., information on risk and consequences). They expected to feel reassured or relieved by negative test results, and sad or worried if a genetic cause was found.ConclusionsOver half of memory clinic patients eligible for DNA‐testing wanted to be tested. This decision was unrelated to demographic, medical or psychosocial characteristics, and mostly based on intuition and considerations regarding family.","PeriodicalId":7471,"journal":{"name":"Alzheimer's & Dementia","volume":"56 1","pages":""},"PeriodicalIF":13.0000,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alzheimer's & Dementia","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/alz.091187","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

BackgroundData‐driven criteria for DNA testing were implemented in routine care of Alzheimer Center Amsterdam. We aimed to explore patients’ perspectives and considerations regarding their decision to (not) be tested for a monogenic cause of their disease.MethodsIn this mixed method study, 150 of 519 new patients visiting Alzheimer Center Amsterdam who fulfilled the criteria were offered DNA‐diagnostics: 86(57%) accepted, 64(43%) did not. In 65/86(76%) cases results were negative, in 14/86(16%) a monogenic cause and in 7/86 (8%) variants of uncertain significance were found (Figure 1). Sex, age, education, family history of dementia, MMSE and diagnosis were retrieved. Before discussing DNA testing, patients completed a questionnaire assessing perceived risk of a genetic cause, susceptibility for, severity of, and experience with dementia, social support, coping strategies, anxiety, depression, and quality of life. Differences between those who did and did not consent to DNA testing were calculated using Pearson’s χ², Mann‐Whitney U or Independent Samples t‐tests; p‐values were FDR‐adjusted. A subset of 22 patients and/or relatives participated in semi‐structured interviews on motivations and considerations regarding their decision. Verbatim transcripts were analyzed inductively using MAXQDA‐software.ResultsParticipants (n = 150) were 46% female and aged 61±8 (MMSE = 22±6, 5 Subjective Cognitive Decline, 9 MCI, 104 dementia [69 AD, 13 FTD, 22 other], 32 other/undetermined). Adjusted for multiple testing, no demographic, medical or psychosocial factors were associated with the decision on DNA testing (all p>0.05). Twenty‐one interviewees who agreed to DNA testing were generally motivated by obtaining information on heredity for their relatives, contributing to scientific research into a treatment, and gaining insight in the cause of their disease. One patient had blood stored, allowing their children to test it when opportune. The majority decided quickly, mostly on intuitions (e.g., responsibility towards relatives) rather than facts (e.g., information on risk and consequences). They expected to feel reassured or relieved by negative test results, and sad or worried if a genetic cause was found.ConclusionsOver half of memory clinic patients eligible for DNA‐testing wanted to be tested. This decision was unrelated to demographic, medical or psychosocial characteristics, and mostly based on intuition and considerations regarding family.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
记忆诊所中患者对DNA检测的看法和考虑:DNA‐ABOARD
数据驱动的DNA检测标准在阿姆斯特丹阿尔茨海默中心的常规护理中实施。我们的目的是探讨患者的观点和考虑到他们决定(不)进行测试的单基因原因的疾病。方法在这项混合方法研究中,519名新到阿姆斯特丹阿尔茨海默中心就诊的符合标准的患者中有150人接受了DNA诊断:86人(57%)接受了DNA诊断,64人(43%)没有接受DNA诊断。65/86(76%)例结果为阴性,14/86(16%)例为单基因原因,7/86(8%)例发现意义不确定的变异(图1)。检索性别、年龄、教育程度、痴呆家族史、MMSE和诊断。在讨论DNA测试之前,患者完成了一份问卷,评估遗传原因的感知风险、痴呆的易感性、严重程度和经历、社会支持、应对策略、焦虑、抑郁和生活质量。使用Pearson χ 2、Mann - Whitney U或独立样本t检验计算同意和不同意进行DNA检测的患者之间的差异;p值经FDR调整。22名患者和/或亲属参加了半结构化访谈,了解他们决定的动机和考虑因素。使用MAXQDA‐软件对逐字转录本进行归纳分析。结果150例参与者中46%为女性,年龄61±8岁(MMSE = 22±6,主观认知能力下降5例,轻度认知障碍9例,痴呆104例[AD 69例,FTD 13例,其他22例],其他/未确定32例)。经多次检测调整后,没有人口统计学、医学或社会心理因素与决定进行DNA检测相关(均p>;0.05)。21位同意进行DNA检测的受访者的动机通常是为他们的亲属获取遗传信息,为治疗的科学研究做出贡献,并了解他们疾病的原因。一名患者将血液储存起来,以便他们的孩子在适当的时候进行检测。大多数人很快就决定了,主要是根据直觉(例如,对亲属的责任)而不是事实(例如,关于风险和后果的信息)。他们期望看到阴性检测结果时感到放心或宽慰,如果发现遗传原因,他们会感到悲伤或担心。结论:超过一半的记忆临床患者有资格进行DNA检测。这一决定与人口、医学或社会心理特征无关,主要基于直觉和对家庭的考虑。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Alzheimer's & Dementia
Alzheimer's & Dementia 医学-临床神经学
CiteScore
14.50
自引率
5.00%
发文量
299
审稿时长
3 months
期刊介绍: Alzheimer's & Dementia is a peer-reviewed journal that aims to bridge knowledge gaps in dementia research by covering the entire spectrum, from basic science to clinical trials to social and behavioral investigations. It provides a platform for rapid communication of new findings and ideas, optimal translation of research into practical applications, increasing knowledge across diverse disciplines for early detection, diagnosis, and intervention, and identifying promising new research directions. In July 2008, Alzheimer's & Dementia was accepted for indexing by MEDLINE, recognizing its scientific merit and contribution to Alzheimer's research.
期刊最新文献
AAIC Satellite Symposium slated for May 14 to 15 in Lima, Peru A multi-cohort study of longitudinal and cross-sectional Alzheimer's disease biomarkers in cognitively unimpaired older adults Malnutrition exacerbating neuropsychiatric symptoms on the Alzheimer's continuum is relevant to the cAMP signaling pathway: Human and mouse studies Compositional brain scores capture Alzheimer's disease–specific structural brain patterns along the disease continuum A neuropathology case report of a woman with Down syndrome who remained cognitively stable: Implications for resilience to neuropathology
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1